(Q43274077)

English

Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction

scientific article published on 3 August 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Yoshimasa Aso

1

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Ruriko Suganuma

2

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Sadao Wakabayashi

3

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Kenji Hara

4

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Tomoki Nakano

5

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Mariko Suetsugu

6

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Sachiko Matsumoto

7

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Takafumi Nakamachi

8

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Kohzo Takebayashi

9

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Kimio Morita

10

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Toshihiko Inukai

11

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

publication date

3 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Translational Research

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

154

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

175-182

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Association of hypoadiponectinemia with coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Adiponectin and development of type 2 diabetes in the Pima Indian population

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Plasma adiponectin levels and risk of myocardial infarction in men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Adiponectin concentrations in sera from patients with type 2 diabetes are negatively associated with sympathovagal balance as evaluated by power spectral analysis of heart rate variation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Ageing and plasma adiponectin concentration in apparently healthy males and females

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Serum adiponectin is increased in type 1 diabetic patients with nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994)

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Anemia and diabetes in the absence of nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Anaemia in diabetic patients with chronic kidney disease--prevalence and predictors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Adiponectin and mortality in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Relationships between plasma adiponectin and blood cells, hepatopancreatic enzymes in women.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

New avenues of exploration for erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Regulation of erythropoietin production

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Anemia and cardiovascular disease in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.07.005

7 January 2021

Identifiers

10.1016/J.TRSL.2009.07.005

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43274077&oldid=1985277041"